Insider

UnitedHealth Group reported adjusted earnings of $4.69 per share in the third quarter of 2026

UnitedHealth Group reported adjusted net earnings of $4.69 per share for the third quarter 2026. Revenue was $112.7 billion, slightly below $113.2 billion in the comparable quarter 2025. The operating cost ratio fell to 12.8% from 13.5%, and the medical cost ratio fell to 88.4% from 89.9%. The debt‑to‑capital ratio rose to 41.7% as of September 30, 2026. The company repurchased $5.0 billion of its common stock and paid $6.2 billion in dividends year to date.

Verified against 2 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
Four professionals in a modern office meeting space
Photo by Vitaly Gariev on Unsplash
$4.69 per share
Adjusted earnings

Key points

  • UnitedHealth Group posted adjusted earnings of $4.69 per share in the third quarter 2026.
  • The company said the 12.8% operating cost ratio reflects investments in operations, consumer and clinician experiences, and technology.

What happened

UnitedHealth Group posted adjusted earnings of $4.69 per share in the third quarter 2026. Revenue was $112.7 billion, slightly below $113.2 billion in 2025. The operating cost ratio was 12.8% versus 13.5% a year earlier. The medical cost ratio was 88.4% versus 89.9% a year earlier. The debt‑to‑capital ratio increased to 41.7%. The company bought back $5.0 billion of its own shares and paid $6.2 billion in dividends for the year.

Revenue by quarter, $B

101Q4 '24*7.7%110Q1 '258.3%112Q2 '254.6%113Q3 '253.8%113Q4 '25*0.3%112Q1 '268%112Q2 '267.1%113Q3 '265.8%
Bottom row: operating margin (operating income divided by revenue). Q4 = fiscal year minus the three quarters reported on their own. Revenue as the company tagged it in its SEC filings (XBRL). Guidance is the company's own, not our forecast.

Sector context: 36 covered companies in Health Care reported a median revenue change of +7.2% YoY in their latest filings.

Company explanation

The company said the 12.8% operating cost ratio reflects investments in operations, consumer and clinician experiences, and technology. The 88.4% medical cost ratio results from medical cost‑management actions, benefit‑design changes and pricing discipline.

What to watch

Investors should monitor changes in the debt‑to‑capital ratio next quarter, as its level affects financial resilience.

Original sources

  1. 8-K EX-99.1 filing, October 13, 2026October 13, 2026SHA-256 of our archived copy fc8e4721b083…
  2. 8-K EX-99.2 filing, October 13, 2026October 13, 2026SHA-256 of our archived copy 78d428d28af0…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards